Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2013 1
2014 6
2015 2
2016 2
2017 2
2018 3
2019 2
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis.
Dercle L, Zhao B, Gönen M, Moskowitz CS, Firas A, Beylergil V, Connors DE, Yang H, Lu L, Fojo T, Carvajal R, Karovic S, Maitland ML, Goldmacher GV, Oxnard GR, Postow MA, Schwartz LH. Dercle L, et al. Among authors: beylergil v. JAMA Oncol. 2022 Mar 1;8(3):385-392. doi: 10.1001/jamaoncol.2021.6818. JAMA Oncol. 2022. PMID: 35050320 Free PMC article. Clinical Trial.
The role of initial chest X-ray in triaging patients with suspected COVID-19 during the pandemic.
Kim HW, Capaccione KM, Li G, Luk L, Widemon RS, Rahman O, Beylergil V, Mitchell R, D'Souza BM, Leb JS, Dumeer S, Bentley-Hibbert S, Liu M, Jambawalikar S, Austin JHM, Salvatore M. Kim HW, et al. Among authors: beylergil v. Emerg Radiol. 2020 Dec;27(6):617-621. doi: 10.1007/s10140-020-01808-y. Epub 2020 Jun 22. Emerg Radiol. 2020. PMID: 32572707 Free PMC article.
Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.
O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, Fox JJ, Ruan S, Zanzonico PB, Ragupathi G, Lyashchenko SK, Williams SP, Scher HI, Fine BM, Humm JL, Larson SM, Morris MJ, Carrasquillo JA. O'Donoghue JA, et al. Among authors: beylergil v. Mol Pharm. 2019 Jul 1;16(7):3083-3090. doi: 10.1021/acs.molpharmaceut.9b00326. Epub 2019 May 31. Mol Pharm. 2019. PMID: 31117485 Free PMC article.
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer.
O'Donoghue JA, Lewis JS, Pandit-Taskar N, Fleming SE, Schöder H, Larson SM, Beylergil V, Ruan S, Lyashchenko SK, Zanzonico PB, Weber WA, Carrasquillo JA, Janjigian YY. O'Donoghue JA, et al. Among authors: beylergil v. J Nucl Med. 2018 Jan;59(1):161-166. doi: 10.2967/jnumed.117.194555. Epub 2017 Jun 21. J Nucl Med. 2018. PMID: 28637800 Free PMC article. Clinical Trial.
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).
Abou-Alfa GK, Yen CJ, Hsu CH, O'Donoghue J, Beylergil V, Ruan S, Pandit-Taskar N, Gansukh B, Lyashchenko SK, Ma J, Wan P, Shao YY, Lin ZZ, Frenette C, O'Neil B, Schwartz L, Smith-Jones PM, Ohtomo T, Tanaka T, Morikawa H, Maki Y, Ohishi N, Chen YC, Agajanov T, Boisserie F, Di Laurenzio L, Lee R, Larson SM, Cheng AL, Carrasquilo JA. Abou-Alfa GK, et al. Among authors: beylergil v. Cancer Chemother Pharmacol. 2017 Feb;79(2):421-429. doi: 10.1007/s00280-017-3241-9. Epub 2017 Jan 24. Cancer Chemother Pharmacol. 2017. PMID: 28120036 Free PMC article. Clinical Trial.
Copper-64 trastuzumab PET imaging: a reproducibility study.
Carrasquillo JA, Morris PG, Humm JL, Smith-Jones PM, Beylergil V, Akhurst T, O'donoghue JA, Ruan S, Modi S, Hudis CA, Larson SM. Carrasquillo JA, et al. Among authors: beylergil v. Q J Nucl Med Mol Imaging. 2019 Jun;63(2):191-198. doi: 10.23736/S1824-4785.16.02867-3. Epub 2016 May 12. Q J Nucl Med Mol Imaging. 2019. PMID: 27171605 Free PMC article. Clinical Trial.
22 results